ArticleMolecular cancer therapeutics2021

Discovery and Pharmacological Characterization of JNJ-64619178, a Novel Small-Molecule Inhibitor of PRMT5 with Potent Antitumor Activity.

Dirk Brehmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.